Wieden & Kennedy wins global Nurofen business

Reckitt Benckiser has appointed Wieden & Kennedy London to handle the global advertising business for its ibuprofen brand, Nurofen, after a review.

Nurofen: appoints Wieden & Kennedy
Nurofen: appoints Wieden & Kennedy

The incumbent is Havas Worldwide, which pitched for the account along with McCann Erickson. Havas, formerly known as Euro RSCG, won back the business at the end of 2010 after losing it to Mother in 2009. It had originally picked up the consolidated £800 million RB account in July 2006.

In 2014, RB moved three of its power brands – Air Wick, Clearasil and Finish – from Havas Worldwide to Wieden & Kennedy and Droga5 New York after a competitive pitch.

Roberto Funari, the executive vice president of global category development at RB, said: "We're delighted that Wieden & Kennedy will be partnering with us on this key consumer health brand. The quality of the strategic and creative thinking we have seen throughout the review has been superb."


Market Reports

Get unprecedented new-business intelligence with access to Campaign’s new Advertising Intelligence Market Reports.

Find out more

Enjoying Campaign’s content?

 Get unlimited access to Campaign’s premium content for your whole company with a corporate licence.

Upgrade access

Looking for a new job?

Get the latest creative jobs in advertising, media, marketing and digital delivered directly to your inbox each day.

Create an alert now

Partner content